Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TRIQK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC101926921 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C10orf10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
UBR5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP11A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EMB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RTTN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01004 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CFLAR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LIPF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100505786 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTC39B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNFRSF19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TFPI - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01098 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHST15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on